The Valley Desk

NCT00774397 · Interventional trial

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Overall registry status Completed

Phase 2

Conditions Hepatitis C, Chronic

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov